FDA Approves New Treatment for Travelers’ Diarrhea
Aemcolo is a broad spectrum, semi-synthetic, orally-administered, minimally-absorbed antibiotic designed to allow for delayed release to the colon.
MPR YIR Gastro 2018
Hepatocellular Carcinoma Risk Following Antiviral Therapy for HCV Examined
The retrospective study aimed to determine the risk of incident, or de novo, HCC following different regimens of antiviral therapy.
DAA Treatment and Hepatic Fibrosis Improvement in HCV: What’s the Link?
The study aimed to determine whether direct-acting antiviral therapy reduced fibrosis and assessed whether any predictors of treatment failure existed at 1-year follow-up.
AGA: New Opioid-Induced Constipation Management Guidelines Available
The recommendations have been published in the AGA’s official journal, Gastroenterology.
Novel Blood Test for Irritable Bowel Syndrome Now Available
The test works by measuring levels of anti-cytolethal distending toxin B (CdtB) and anti-vinculin, 2 biomarkers of post-infectious IBS-D and IBS-M.
Reflux Band Now Available OTC for Reducing Laryngopharyngeal Reflux
In one study, 86% of patients clinically diagnosed with esophagopharyngeal reflux reported significant reduction in symptoms after 2 weeks of use.
Antibiotic Tx Appears to Be a Reasonable Option for Uncomplicated Acute Appendicitis
The study included 530 patients, aged 18 to 60 years, with computed tomography-confirmed uncomplicated acute appendicitis.
On-Demand PPI Use Examined in Non-Erosive Reflux Disease, Mild Erosive Esophagitis
Results of the study found on-demand PPI use to be superior to daily administration of a PPI (pooled OR: 0.50; 95% CI: 0.35, 0.72).
Secretagogues Compared in Irritable Bowel Syndrome With Constipation
While several secretagogues have been recently approved by the Food and Drug Administration (FDA), a lack of head-to-head trials led researchers to conduct a systematic review to compare the effectiveness of these agents in patients with IBS-C.
Treatments for Primary Prevention of Esophageal Variceal Bleeding Compared
Treatments (NSBB, isosorbide mononitrate, carvedilol, variceal band ligation) were compared as monotherapy or as combination therapy with each other or versus placebo.
